TCL Archive DCE Board Approves Concepts For New Chemoprevention Groups, Retroviral Vaccine Research, Biochemical Markers, Feline Virus Studies March 15, 1985
TCL Archive CTEP’s Clinical Trials Proposals Reshaped By Discussion: BSC Next On Schedule May 9, 1986
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005